Answer
Darifenacin hydrobromide is a selective muscarinic M3 receptor antagonist in vitro, targeting the major receptor subtype controlling bladder muscle contraction, although whether this selectivity provides any clinical advantage in overactive bladder is unknown.
Sources for this answer
- Emselex 7.5mg prolonged-release tabletspharmaand GmbH · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked